Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.171EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.171EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.171ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.171ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.171EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.171EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.171ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.171ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.57EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.57ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.57ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.57EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.57EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.57ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.67EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.67ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.67ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.67EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.67EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.67ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.279EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.279EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.279ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.279ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.279EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.279EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.279ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.279ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.67EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.67ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.67ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.67EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.67EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.67ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-18330.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used